Technology | Nuclear Imaging | October 19, 2017

Biodex Unveils Atomlab 500 Dose Calibrator and Wipe Test Counter

Next-generation system features sleek new design, enhanced user experience and improved connectivity for the modern technologist or radiopharmacy

Biodex Unveils Atomlab 500 Dose Calibrator and Wipe Test Counter

October 19, 2017 — Biodex Medical Systems announced the full release of the Atomlab Dose Calibrator and Wipe Test Counter to the market following the initial unveiling at the Society for Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting in June.

External updates include a new silver exterior and large tablet display. Internal updates on the new Windows-based tablet make available more connectivity options to the user. Ethernet and serial ports enable seamless integration with the most popular nuclear medicine management systems. Results are stored on the unit using a robust SQL database, and PDF reports can be generated for easy printing. USB port allows for convenient backup of quality assurance (QA) data and connection to an external monitor or printer. 

Easy-to-use interface, intuitive menus and automated quality assurance apps help simplify and improve accuracy of dose calibration and quality control. With more integrated software and connectivity, the new Atomlab 500 Dose Calibrator, Wipe Test Counter, and Atomlab 500Plus combination will enable compatibility with future software updates and ensure a long life for the system.

For more information: www.biodex.com

Related Content

Versatile, future-proof digital imaging unit scales to meet growing technology needs of customers
News | Digital Radiography (DR) | August 06, 2020
August 6, 2020 — Carestream Health has launched its...
New Medical Imaging and Data Resource Center will aid AI development and medical advancement to battle COVID-19

Getty Images

News | Coronavirus (COVID-19) | August 05, 2020
August 5, 2020 — The nation’s largest medical imaging associations are working together to develop the new Medical Im
Mobile CT scanner reimagines head imaging of critically ill patients by enabling patients and staff to remain in ICU
News | Computed Tomography (CT) | August 05, 2020
August 5, 2020 — The Food and Drug Administration (FDA) has cleared the...
Siemens AG is continuing to rigorously execute its Vision 2020+ strategy and therefore expressly welcomes Siemens Healthineers AG’s acquisition of a 100 percent stake in Varian Medical Systems, Inc., a U.S. company active in the area of cancer research and therapy.

Getty Images

News | Radiology Business | August 03, 2020
August 3, 2020 — Siemens AG is continuing to rigorously execute its Vision 2020+ strategy and therefore expressly wel
A World Health Organization (WHO) rapid advice guide on the use of chest imaging in the diagnosis and management of COVID-19 was published in the journal Radiology.

Getty Images

News | Coronavirus (COVID-19) | July 30, 2020
July 30, 2020 — A World Health Organization (WHO) rapid advice gui
 The Radiological Society of North America (RSNA) has been awarded a $750,000 grant by the Department of Energy’s National Nuclear Security Administration (NNSA) to develop a Global Learning Center (GLC) in Sub-Saharan Africa. The grant will help address the growing need in Sub-Saharan Africa for training in radiology.
News | Radiology Education | July 28, 2020
July 28, 2020 — The Radiological Society of North America (RSNA)
In I-131 cancer therapy, decay events damage sensitive DNA within a tumor cell nucleus, causing catastrophic single and double strand breaks. Clinical use of antibody-delivered Auger emitters could open a window for the targeted destruction of extracellular COVID-19 virions, decreasing the viral load during active infection and potentially easing the disease burden for a patient. View all figures from this study.  http://jnm.snmjournals.org/content/early/2020/07/16/jnumed.120.249748.full.pdf+html

In I-131 cancer therapy, decay events damage sensitive DNA within a tumor cell nucleus, causing catastrophic single and double strand breaks. Clinical use of antibody-delivered Auger emitters could open a window for the targeted destruction of extracellular COVID-19 virions, decreasing the viral load during active infection and potentially easing the disease burden for a patient. View all figures from this study.

 

News | Coronavirus (COVID-19) | July 22, 2020 | Dave Fornell, Editor
July 22, 2020 — One of the first studies has been published that looks at the use of...
RSNA 2020: Human Insight/Visionary Medicine, will be held as an all-virtual event, Nov. 29 – Dec. 5, 2020
News | RSNA | July 22, 2020
July 22, 2020 — Registration is now open for the Radiological Society of North America (...
News | Coronavirus (COVID-19) | July 20, 2020
July 20, 2020 — Racial/ethnic minority patients admitted to the hospital with...